The role of disturbed blood flow in the development of pulmonary arterial hypertension: lessons from preclinical animal models.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajplung.00031.2013PMID 23624788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The monocrotaline model of pulmonary hypertension in perspective.

  2012cited by this paper
• Modern age pathology of pulmonary arterial hypertension.

  2012cited by this paper
• MicroRNA-21 Integrates Pathogenic Signaling to Control Pulmonary Hypertension: Results of a Network Bioinformatics Approach

  2012cited by this paper
• A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

  2012cited by this paper
• Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension.

  2012cited by this paper
• Towards Systems Biology of Pulmonary Hypertension

  2012cited by this paper
• Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure‐loaded right ventricle

  2012cited by this paper
• Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure.

  2011cited by this paper
• Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension

  2011cited by this paper
• Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.

  2011cited by this paper
• Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load

  2011cited by this paper
• Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.

  2011cited by this paper
• Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

  2011cited by this paper
• Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT

  2011cited by this paper
• Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

  2010cited by this paper
• Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

  2010cited by this paper
• The Effects of Antiangiogenic Compound SU5416 in a Rat Model of Pulmonary Arterial Hypertension

  2010cited by this paper
• Gene expression profile in flow-associated pulmonary arterial hypertension with neointimal lesions.

  2010cited by this paper
• Management of pulmonary arterial hypertension in children.

  2010cited by this paper
• Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension.

  2010cited by this paper
• Shear stress and the endothelial transport barrier.

  2010cited by this paper
• Formation of Plexiform Lesions in Experimental Severe Pulmonary Arterial Hypertension

  2010cited by this paper
• Reversible or irreversible remodeling in pulmonary arterial hypertension.

  2010cited by this paper
• Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology

  2009cited by this paper
• Guidelines for the diagnosis and treatment of pulmonary hypertension

  2009cited by this paper
• The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension.

  2009cited by this paper
• Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure.

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Inflammation, growth factors, and pulmonary vascular remodeling.

  2009cited by this paper
• Guidelines for the diagnosis and treatment of pulmonary hypertension

  2009cited by this paper
• Updated clinical classification of pulmonary hypertension.

  2009cited by this paper
• Interleukin-6 Overexpression Induces Pulmonary Hypertension

  2009cited by this paper
• Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension

  2008cited by this paper
• Molecular pathogenesis of pulmonary arterial hypertension.

  2008cited by this paper
• Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.

  2008cited by this paper
• Molecular pathogenesis of pulmonary arterial hypertension.

  2008cited by this paper
• The cancer paradigm of severe pulmonary arterial hypertension.

  2008cited by this paper
• Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension.

  2008cited by this paper
• Role of shear stress direction in endothelial mechanotransduction.

  2008cited by this paper
• Pulmonary arterial hypertension in congenital cardiac disease – the need for refinement of the Evian-Venice classification

  2008cited by this paper
• Effects of erythropoietin on advanced pulmonary vascular remodelling

  2008cited by this paper
• Progressive dysfunction of nitric oxide synthase in a lamb model of chronically increased pulmonary blood flow: a role for oxidative stress.

  2008cited by this paper
• Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.

  2007cited by this paper
• Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension.

  2007cited by this paper
• Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds

  2007cited by this paper
• Pathology of pulmonary hypertension.

  2007cited by this paper
• Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms

  2007cited by this paper
• Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease.

  2007cited by this paper
• Pathobiology of pulmonary hypertension.

  2007cited by this paper
• Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

  2006cited by this paper
• Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling

  2006cited by this paper
• Treprostinil in Advanced Experimental Pulmonary Hypertension: Beneficial Outcome Without Reversed Pulmonary Vascular Remodeling

  2006cited by this paper
• Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.

  2006cited by this paper
• Development of Occlusive Neointimal Lesions in Distal Pulmonary Arteries of Endothelin B Receptor—Deficient Rats: A New Model of Severe Pulmonary Arterial Hypertension

  2005cited by this paper
• The role of increased pulmonary blood flow in pulmonary arterial hypertension

  2005cited by this paper
• Initial apoptosis is followed by increased proliferation of apoptosis‐resistant endothelial cells

  2005cited by this paper
• Reversal of experimental pulmonary hypertension by PDGF inhibition.

  2005cited by this paper
• Cellular and molecular pathobiology of pulmonary arterial hypertension.

  2004cited by this paper
• Treatment of pulmonary arterial hypertension.

  2004cited by this paper
• Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats.

  2004cited by this paper
• S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy.

  2004cited by this paper
• Oxidative stress in severe pulmonary hypertension.

  2004cited by this paper
• Signaling Molecules in Overcirculation-Induced Pulmonary Hypertension in Piglets: Effects of Sildenafil Therapy

  2004cited by this paper
• Surgically induced unilateral pulmonary hypertension: time-related analysis of a new experimental model.

  2003cited by this paper
• Emergence of Smooth Muscle Cell Endothelin B–Mediated Vasoconstriction in Lambs With Experimental Congenital Heart Disease and Increased Pulmonary Blood Flow

  2003cited by this paper
• Bosentan for the Prevention of Overcirculation-Induced Experimental Pulmonary Arterial Hypertension

  2003cited by this paper
• Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension.

  2003cited by this paper
• Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow.

  2003cited by this paper
• Species comparison of lung development.

  2003cited by this paper
• Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.

  2002cited by this paper
• Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats.

  2002cited by this paper
• Catalytic Antisense DNA Molecules Targeting Egr-1 Inhibit Neointima Formation following Permanent Ligation of Rat Common Carotid Arteries

  2002cited by this paper
• SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase.

  2002cited by this paper
• Comparison of rat and mouse pulmonary tissue mechanical properties and histology.

  2002cited by this paper
• 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats.

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001cited by this paper
• Enhanced expression of vascular endothelial growth factor in pulmonary plexogenic arteriopathy due to congenital heart disease

  2000cited by this paper
• Altered Regulation of the ET-1 Cascade in Lambs with Increased Pulmonary Blood Flow and Pulmonary Hypertension

  2000cited by this paper
• Systemic lobar shunting induces advanced pulmonary vasculopathy.

  2000cited by this paper
• Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease.

  1999cited by this paper
• Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

  1999cited by this paper
• Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation.

  1998cited by this paper
• Hemodynamics modulate pulmonary artery response to injury.

  1998cited by this paper
• Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension.

  1997cited by this paper
• Chronic pulmonary hypertension in sheep: temporal progression of lesions.

  1996cited by this paper
• The role of vascular injury and hemodynamics in rat pulmonary artery remodeling.

  1996cited by this paper
• Pulmonary hypertension and arterial changes in calves with a systemic-to-left pulmonary artery connection.

  1994cited by this paper
• Simple, rapid, and effective method of producing aortocaval shunts in the rat.

  1990cited by this paper
• Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study.

  1990cited by this paper
• Biopsy pathology of the pulmonary vasculature

  1989cited by this paper
• The postnatal development and growth of the human lung. I. Morphometry.

  1987cited by this paper
• The postnatal development and growth of the human lung. II. Morphology.

  1987cited by this paper
• Aorta-pulmonary shunts in growing pigs. Functional and structural assessment of the changes in the pulmonary circulation.

  1979cited by this paper
• Compensatory growth of the lung following pneumonectomy.

  1973cited by this paper
• PULMONARY VASCULAR CHANGES IN A DOG AFTER AORTOPULMONARY ANASTOMOSIS FOR FOUR YEARS

  1959cited by this paper
• THE PHYSIOLOGICAL PRINCIPLE OF MINIMUM WORK APPLIED TO THE ANGLE OF BRANCHING OF ARTERIES

  1926cited by this paper

• Deciphering the Counterintuitive Role of Vascular Endothelial Growth Factor Signaling Pathways in Pulmonary Arterial Hypertension

  2026cites this paper
• TARGETING LUNG HEME IRON BY AEROSOL HEMOPEXIN ADMINSTRATION IN SICKLE CELL DISEASE PULMONARY HYPERTENSION.

  2025cites this paper
• Sarcoidosis-Associated Pulmonary Hypertension

  2025cites this paper
• The Role of Hydrogen Sulfide in the Regulation of the Pulmonary Vasculature in Health and Disease

  2025influential citation
• Biophysical and Biochemical Roles of Shear Stress on Endothelium: A Revisit and New Insights

  2025influential citation
• Nanoparticle-driven drug delivery system for cardiovascular treatment.

  2025cites this paper
• Shear stress unveils patient-specific transcriptional signatures in PAH: Towards personalized molecular diagnostics

  2025cites this paper
• SUL-150 Limits Vascular Remodeling and Ventricular Failure in Pulmonary Arterial Hypertension

  2025cites this paper
• Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertension

  2025cites this paper
• Scoping review of post‐TB pulmonary vascular disease: Proceedings from the 2nd International Post‐Tuberculosis Symposium

  2024cites this paper
• Defective CFTR modulates mechanosensitive channels TRPV4 and PIEZO1 and drives endothelial barrier failure

  2024cites this paper
• G6pdN126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker‐Induced Pulmonary Vascular Disease

  2024cites this paper
• --------ATIC promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.

  2024cites this paper
• Vascular Inflammatory Diseases and Endothelial Phenotypes

  2023cites this paper
• Transpulmonary generation of cell‐free hemoglobin contributes to vascular dysfunction in pulmonary arterial hypertension via dysregulated clearance mechanisms

  2023cites this paper
• Simvastatin restores pulmonary endothelial function in the setting of pulmonary over-circulation

  2023cites this paper
• Beyond CFD: Emerging methodologies for predictive simulation in cardiovascular health and disease.

  2023cites this paper
• CD39 in the development and progression of pulmonary arterial hypertension

  2022cites this paper
• NBL1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.

  2022cites this paper
• Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention

  2022cites this paper
• Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension

  2022cites this paper
• Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.

  2022cites this paper
• General discussion, conclusion remark, and future direction

  2021cites this paper
• In Vitro Measurements of Cellular Forces and their Importance in the Lung—From the Sub- to the Multicellular Scale

  2021cites this paper
• Animal Models of PAH and Increased Pulmonary Blood Flow

  2021cites this paper
• Computational simulation-derived hemodynamic and biomechanical properties of the pulmonary arterial tree early in the course of ventricular septal defects

  2021cites this paper
• Delivery of Anti‐microRNA‐712 to Inflamed Endothelial Cells Using Poly(β‐amino ester) Nanoparticles Conjugated with VCAM‐1 Targeting Peptide

  2021cites this paper
• Endothelial progenitor cells in pulmonary diseases, repair and regeneration

  2021cites this paper
• Pulmonary hypertension after pneumonectomy: a preclinical model in rats and human pulmonary endothelial cells.

  2020cites this paper
• The Hemodynamic Characteristics of Right Ventricle After Gradient Pulmonary Artery Banding in Rats

  2020cites this paper
• Sarcoidosis-Associated Pulmonary Hypertension

  2020cites this paper
• Image diagnosis: Eisenmenger’s syndrome in patients with simple congenital heart disease

  2020cites this paper
• High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension

  2020cites this paper
• Animal models of right heart failure.

  2020cites this paper
• Lesões Plexiformes na Hipertensão Arterial Pulmonar: Estamos Ficando mais Próximos do Manejo com mais Paciência e Rigor?

  2020cites this paper
• Medical Image-Based Hemodynamic Analyses in a Study of the Pulmonary Artery in Children With Pulmonary Hypertension Related to Congenital Heart Disease

  2020cites this paper
• Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension

  2019cites this paper
• Vascular syndromes in liver cirrhosis

  2019cites this paper
• Converging Paths of Pulmonary Arterial Hypertension and Cellular Senescence.

  2019cites this paper
• The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats.

  2019cites this paper
• Living Donor Liver Transplantation in Biliary Atresia Children with Pulmonary Hypertension

  2019cites this paper
• ORAI Channels as Potential Therapeutic Targets in Pulmonary Hypertension.

  2018cites this paper
• Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up

  2018cites this paper
• Transition from post‐capillary pulmonary hypertension to combined pre‐ and post‐capillary pulmonary hypertension in swine: a key role for endothelin

  2018cites this paper
• Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.

  2018cites this paper
• A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

  2018cites this paper
• Balloon pulmonary angioplasty relieves haemodynamic stress towards untreated-side pulmonary vasculature and improves its resistance in patients with chronic thromboembolic pulmonary hypertension.

  2018cites this paper
• Modeling Pulmonary Hypertension: A Pig Model of Postcapillary Pulmonary Hypertension.

  2018cites this paper
• Sarcoidosis-associated Pulmonary Hypertension: Pathophysiology, Diagnosis, and Treatment

  2018cites this paper
• Chapter 2 Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress

  2018cites this paper
• Assessment of reversibility in pulmonary arterial hypertension and congenital heart disease

  2018cites this paper
• Präkapilläre pulmonale Hypertonie und schlafbezogene Atmungsstörungen: Gibt es einen Zusammenhang?

  2018cites this paper
• Potentiel thérapeutique de l'inhibition d'HDAC6 en hypertension artérielle pulmonaire

  2017cites this paper
• Mouse models of chronic obstructive pulmonary disease : in search of novel treatment options

  2017cites this paper
• miR-21 is associated with fibrosis and right ventricular failure.

  2017cites this paper
• Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease

  2017cites this paper
• Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension.

  2017cites this paper
• Compromiso pulmonar en la enfermedad hepática: una actualización

  2017cites this paper
• Prognostic factors, treatment goals and clinical endpoints in pediatric pulmonary arterial hypertension

  2017influential citation
• New Thoughts about the Origin of Plexiform Lesions.

  2016cites this paper
• Egr-1 identifies neointimal remodeling and relates to progression in human pulmonary arterial hypertension.

  2016cites this paper
• Targeting the Cause, affecting the Course: Characterization and Optimization of Experimental Models for Pulmonary Arterial Hypertension

  2016cites this paper
• Pulmonary endothelial HIF2$\alpha$-arginase axis plays an essential role in the development of hypoxia pulmonary hypertension

  2016cites this paper
• Inhibition of survivin promotes pulmonary arterial smooth muscle cell apoptosis in high blood flow-induced pulmonary arterial hypertension in rats

  2016cites this paper
• Precapillary Pulmonary Hypertension and Sleep-Disordered Breathing: Is There a Link?

  2016cites this paper
• Pneumonectomy combined with SU 5416 induces severe pulmonary hypertension in rats

  2016cites this paper
• HIF2α–arginase axis is essential for the development of pulmonary hypertension

  2016cites this paper
• Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.

  2016cites this paper
• How does pulmonary endarterectomy cure CTEPH: A clue to cure PAH?

  2016cites this paper
• High blood pressure: An obscuring misnomer?

  2016cites this paper
• CHAPTER 5 Delayed microvascular shear adaptation in Pulmonary Arterial Hypertension : role of Platelet Endothelial Cell Adhesion Molecul-1 cleavage

  2016cites this paper
• Chronic hypoxia does not cause wall thickening of intra‐acinar pulmonary supernumerary arteries

  2016cites this paper
• Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension.

  2016cites this paper
• Icariin Inhibits Pulmonary Hypertension Induced by Monocrotaline through Enhancement of NO/cGMP Signaling Pathway in Rats

  2016cites this paper
• Anesthesia for Patients with Concomitant Hepatic and Pulmonary Dysfunction.

  2016influential citation
• Pneumonectomy combined with SU5416 induces severe pulmonary hypertension in rats.

  2016cites this paper
• Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.

  2016cites this paper
• RhoA ACTIVITY IS SPATIALLY ASSOCIATED WITH BARRIER DISRUPTING DISTANT CONTRACTILE F-ACTIN FIBERS OR RE-ANNEALING MEMBRANE PROTRUSIONS DEPENDENT ON THE ACTIVATION STATUS OF THE ENDOTHELIUM

  2016cites this paper
• Adverse pulmonary vascular remodeling in the Fontan circulation.

  2015cites this paper
• Right ventricular failure due to chronic pressure load: What have we learned in animal models since the NIH working group statement?

  2015cites this paper
• Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.

  2015cites this paper
• Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.

  2015cites this paper
• Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension.

  2015cites this paper
• Hypoxic‐ischemic gene expression profile in the isolated variant of biliary atresia

  2015cites this paper
• Chronic overcirculation-induced pulmonary arterial hypertension in aorto-caval shunt.

  2014cites this paper
• A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension.

  2014cites this paper
• DAS PROPRIEDADES MECÂNICAS DO SISTEMA RESPIRATÓRIO DE RATOS COM HIPERTENSÃO ARTERIAL PULMONAR E SEPSE

  2014cites this paper
• Peer Reviewed Title: Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow

  2014cites this paper
• Hepato-cardiac disorders.

  2014cites this paper
• Endothelial progenitor cells and pulmonary arterial hypertension.

  2014cites this paper
• Right Ventricular Adaptation in Congenital Heart Diseases

  2014cites this paper
• Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow.

  2014cites this paper
• Pulmonary complications in chronic liver disease

  2014cites this paper
• Distinct loading conditions reveal various patterns of right ventricular adaptation.

  2013cites this paper